No Data
No Data
No Data
No Data
No Data
Kiromic Biopharma Outlines Vision in Stakeholder Meetings
TipRanksApr 20 04:43
Kiromic BioPharma Files to Withdraw Registration Statement
Seeking AlphaApr 11 05:19
Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial
PDF Version Favorable Safety and Tolerability also Observed HOUSTON--(BUSINESS WIRE)--Mar. 19, 2024-- Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") reports early efficacy res
Kiromic BioPharmaMar 19 12:00
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
Yahoo FinanceMar 8 21:35
Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024
Yahoo FinanceMar 5 21:35
Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
PDF Version Third Patient Enrolled in Deltacel-01 Completes Treatment HOUSTON--(BUSINESS WIRE)--Mar. 1, 2024-- Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") announces that Vi
Kiromic BioPharmaMar 1 13:00
No Data
No Data